87 related articles for article (PubMed ID: 30093208)
21. Letter to the Editor. Influence of rare RNF213 variants other than p.R4810K on the clinical outcomes of moyamoya disease.
Nomura S; Kawashima A; Akagawa H; Kawamata T
J Neurosurg; 2018 Aug; 129(2):563-565. PubMed ID: 29999444
[No Abstract] [Full Text] [Related]
22. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
23. Rapid contralateral progression of focal cerebral arteriopathy distinguished from RNF213-related moyamoya disease and fibromuscular dysplasia.
Araki Y; Takagi Y; Mineharu Y; Kobayashi H; Miyamoto S; Wakabayashi T
Childs Nerv Syst; 2017 Aug; 33(8):1405-1409. PubMed ID: 28497183
[TBL] [Abstract][Full Text] [Related]
24. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
25. Temporal profile of the vascular anatomy evaluated by 9.4-tesla magnetic resonance angiography and histological analysis in mice with the R4859K mutation of RNF213, the susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Ito A; Sakata H; Sato-Maeda M; Morita-Fujimura Y; Kure S; Tominaga T
Brain Res; 2015 Oct; 1624():497-505. PubMed ID: 26315378
[TBL] [Abstract][Full Text] [Related]
26. RNF213 rs112735431 polymorphism in intracranial artery steno-occlusive disease and moyamoya disease in Koreans.
Park MG; Shin JH; Lee SW; Park HR; Park KP
J Neurol Sci; 2017 Apr; 375():331-334. PubMed ID: 28320162
[TBL] [Abstract][Full Text] [Related]
27. RNF213 Variant Diversity Predisposes Distinct Populations to Dissimilar Cerebrovascular Diseases.
Lin J; Sheng W
Biomed Res Int; 2018; 2018():6359174. PubMed ID: 30671466
[TBL] [Abstract][Full Text] [Related]
28. Transient middle cerebral artery occlusion in mice induces neuronal expression of RNF213, a susceptibility gene for moyamoya disease.
Sato-Maeda M; Fujimura M; Kanoke A; Morita-Fujimura Y; Niizuma K; Tominaga T
Brain Res; 2016 Jan; 1630():50-5. PubMed ID: 26556774
[TBL] [Abstract][Full Text] [Related]
29. Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene.
Sonobe S; Fujimura M; Niizuma K; Fujimura T; Furudate S; Nishijima Y; Kure S; Tominaga T
Neuroreport; 2014 Dec; 25(18):1442-6. PubMed ID: 25383461
[TBL] [Abstract][Full Text] [Related]
30. Comments on "RNF213 p.R4810k Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease".
Liu JC; Zhang Q
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1717-1720. PubMed ID: 29475584
[No Abstract] [Full Text] [Related]
31. [Difference of one year death and stroke recurrence in ischemic stroke patients with anterior and posterior circulation intracranial atherosclerosis].
Pu YH; Zou XY; Wang YL; Pan YS; Xiang XL; Soo AX; Leung HK; Zhao XQ; Wang CX; Wong JX; Wang YJ; Liu LP
Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(7):502-507. PubMed ID: 29495218
[No Abstract] [Full Text] [Related]
32. Dysregulation of RNF213 promotes cerebral hypoperfusion.
Morimoto T; Enmi JI; Hattori Y; Iguchi S; Saito S; Harada KH; Okuda H; Mineharu Y; Takagi Y; Youssefian S; Iida H; Miyamoto S; Ihara M; Kobayashi H; Koizumi A
Sci Rep; 2018 Feb; 8(1):3607. PubMed ID: 29483617
[TBL] [Abstract][Full Text] [Related]
33. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.
Chong PF; Ogata R; Kobayashi H; Koizumi A; Kira R
Brain Dev; 2015 Sep; 37(8):822-4. PubMed ID: 25547042
[TBL] [Abstract][Full Text] [Related]
34. Posterior cerebral artery territory infarction associated with persistent primitive hypoglossal artery with internal carotid artery atherosclerosis.
Uzawa A; Aotsuka A; Terano T
Intern Med; 2010; 49(5):515-6. PubMed ID: 20190498
[No Abstract] [Full Text] [Related]
35. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
[TBL] [Abstract][Full Text] [Related]
36. Nonatheroscleotic Isolated Middle Cerebral Artery Disease May Be Early Manifestation of Moyamoya Disease.
Kim YJ; Lee JK; Ahn SH; Kim BJ; Kang DW; Kim JS; Kwon SU
Stroke; 2016 Sep; 47(9):2229-35. PubMed ID: 27507861
[TBL] [Abstract][Full Text] [Related]
37. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
[TBL] [Abstract][Full Text] [Related]
38. Nonsyndromic Peripheral Pulmonary Artery Stenosis Is Associated With Homozygosity of RNF213 p.Arg4810Lys Regardless of Co-occurrence of Moyamoya Disease.
Chang SA; Song JS; Park TK; Yang JH; Kwon WC; Kim SR; Kim SM; Cha J; Jang SY; Cho YS; Kim TJ; Bang OY; Song JY; Ki CS; Kim DK
Chest; 2018 Feb; 153(2):404-413. PubMed ID: 28962888
[TBL] [Abstract][Full Text] [Related]
39. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells.
Ohkubo K; Sakai Y; Inoue H; Akamine S; Ishizaki Y; Matsushita Y; Sanefuji M; Torisu H; Ihara K; Sardiello M; Hara T
Sci Rep; 2015 Aug; 5():13191. PubMed ID: 26278786
[TBL] [Abstract][Full Text] [Related]
40. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A
Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
